ASPE

12.4200.24%
TO

Thomas O. Daniel

Lead Independent Director

Dr. Thomas O. Daniel, M.D., Ph.D., also known as Tom, is Independent Director of Aspen Neuroscience, Inc. from March 2020. Dr. Daniel joined the Aspen Neuroscience, Inc. in March 2020. Dr. Daniel is Director of Vividion Therapeutics, Inc. from January 2017. Dr. Daniel was Chairman of the Board of Vividion Therapeutics, Inc. Dr. Daniel is Scientific Advisor of Vir Biotechnology, Inc. from 2019. Dr. Daniel was Director of Vir Biotechnology, Inc. from January 2017 to September 2019. Dr. Daniel is Venture Advisor of Vertex Ventures HC from August 2024. Dr. Daniel is Lead Independent Director of Gossamer Bio, Inc. Dr. Daniel joined the Gossamer Bio, Inc. on January 04, 2018. Dr. Daniel was Independent Director of Gossamer Bio, Inc. from January 04, 2018. Dr. Daniel is Chairman of the Board of Locanabio, Inc. Dr. Daniel is Member of Scientific & Clinical Advisory Board of Equillium, Inc. from May 06, 2019. Dr. Daniel is Member of Scientific & Clinical Advisory Board of Iambic Therapeutics, Inc. from April 2023. Dr. Daniel is Director of Mozart Therapeutics, Inc. Dr. Daniel is Chairman of the Board of Gate Bioscience, Inc. Dr. Daniel was Member of Scientific & Clinical Advisory Board of Section 32, LLC. Dr. Daniel was Executive Officer of Immunex Corporation. Dr. Daniel was Executive Officer of Amgen Inc. Dr. Daniel was Chairman of Celgene Research of Celgene Corporation. Dr. Daniel was employed at Celgene Corporation from December 2006 to March 01, 2016. Dr. Daniel was Director of Epizyme, Inc. Dr. Daniel was employed at Epizyme, Inc. from May 2012 to June 09, 2014. Dr. Daniel was Member of Therapeutic Advisory Board of aTyr Pharma, Inc. Dr. Daniel joined the aTyr Pharma, Inc. on March 01, 2011. Dr. Daniel was Director of Juno Therapeutics, Inc. until March 06, 2018. Dr. Daniel was employed at Juno Therapeutics, Inc. from August 2015 to March 06, 2018. Dr. Daniel was Independent Director of Zafgen, Inc. from March 2016. Dr. Daniel joined the Zafgen, Inc. on March 03, 2016. Dr. Daniel was Member of In Silico Patient Advisory Board of GNS Healthcare, Inc. from April 2020. Dr. Daniel was Chief Scientific Officer of Ambrx, Inc. Dr. Daniel was employed at Ambrx, Inc. until July 2016. Dr. Daniel was Executive Vice President and President of Celgene Research & Early Development of Celgene Limited. Dr. Daniel was Director of PharmAkea, Inc. Dr. Daniel was employed at PharmAkea, Inc. until July 2016. Dr. Daniel was Independent Director of Magenta Therapeutics, Inc. from October 2016. Dr. Daniel was Venture Partner of Arch Venture Partners, L.P. from October 2016. Dr. Daniel was Independent Director of Larimar Therapeutics, Inc. from March 2016 to May 2022. Dr. Daniel was employed at Larimar Therapeutics, Inc. until May 2022. Dr. Daniel was Independent Director of Dianthus Therapeutics, Inc. until September 11, 2023. Dr. Daniel was employed at Dianthus Therapeutics, Inc. until September 11, 2023. Dr. Daniel has B.A. in Chemistry from Southern Methodist University from 1971 to 1974, M.D. from The University of Texas Southwestern Medical Center in 1978.

公司职务